These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 6214989)
21. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects. Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and clinical evaluation of moxalactam in infants and children. Latif R; Thirumoorthi MC; Buckley JA; Kobos DM; Aravind MK; Kauffman RE; Dajani AS Dev Pharmacol Ther; 1981; 3(4):222-31. PubMed ID: 6212231 [TBL] [Abstract][Full Text] [Related]
23. [Comparative pharmacokinetics of moxalactam and other cephalosporins]. Fourtillan JB; Brisson AM Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of cefotetan (YM09330) in humans. Nakagawa K; Koyama M; Tachibana A; Komiya M; Kikuchi Y; Yano K Antimicrob Agents Chemother; 1982 Dec; 22(6):935-41. PubMed ID: 6961888 [TBL] [Abstract][Full Text] [Related]
26. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin. Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177 [TBL] [Abstract][Full Text] [Related]
27. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins]. Baumgärtner M; Dickgiesser N; Müller S; Wundt W Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361 [TBL] [Abstract][Full Text] [Related]
28. Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses. Neu HC; Aswapokee P; Fu KP; Ho I; Matthijssen C Clin Pharmacol Ther; 1980 May; 27(5):677-85. PubMed ID: 6245831 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of moxalactam in patients with normal and impaired renal function. Aronoff GR; Sloan RS; Luft FC J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824 [TBL] [Abstract][Full Text] [Related]
30. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213 [TBL] [Abstract][Full Text] [Related]
31. Absorption, excretion, and clinical efficacy of moxalactam in pediatric patients. Fujii R Rev Infect Dis; 1982; 4 Suppl():S656-63. PubMed ID: 6218579 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
33. Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzer. Polk RE; Stephens GH Am J Hosp Pharm; 1981 Jun; 38(6):866-8. PubMed ID: 6454343 [TBL] [Abstract][Full Text] [Related]
34. Clinical and pharmacokinetic evaluation of moxalactam in infants and children. Varghese M; Khan AJ; Quaye G; Patel U; Kumar K; Evans HE Chemotherapy; 1982; 28(6):417-20. PubMed ID: 6218971 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of the new cephalosporins. Brogard JM; Comte F Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241 [No Abstract] [Full Text] [Related]
36. The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam. Wise R; Baker S; Wright N; Livingston R J Antimicrob Chemother; 1980 May; 6(3):319-22. PubMed ID: 6447137 [No Abstract] [Full Text] [Related]
38. Pharmacology of ceftizoxime compared with that of cefamandole. Neu HC; Srinivasan S Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631 [TBL] [Abstract][Full Text] [Related]